L. Gavara et al. / Tetrahedron 64 (2008) 4999–5004
5003
(CH3), 22.1 (CH2), 23.9 (CH2), 31.1 (CH2), 50.2 (CH3), 50.3 (CH3), 50.7
(CH), 51.3 (CH3), 61.2 (CH), 105.5 (C), 117.0 (C), 148.8 (C), 152.2 (C),
155.2 (C), 163.8 (C), 168.0 (C), 170.1 (C); IR: n cmꢁ1 1738, 1719, 1654,
1436, 1259, 1209. Anal. Calcd for C17H20BrNO7: C, 47.46; H, 4.69; N,
3.26. Found: C, 47.25; H, 4.77; N; 3.20.
CO2CH3), 3.81, 3.82 (2s, 3H, CO2CH3), 4.42, 4.43 (2dd, J¼8, 3.6 Hz
and J¼8.2, 3.7 Hz, 1H, CHCH2CH3), 5.14–5.23 (m, 1H, CH2CH2CH);
13C NMR: (CDCl3, 50 MHz) d 12.4 (CH3), 23.4 (CH2), 25.6 (CH2), 32.8
(CH2), 49.1 (CH), 51.8 (CH3), 51.9 (CH3), 52.9 (CH3), 62.6 (CH), 106.8
(C),125.3 (C),148 (C),153 (C),156.6 (C),165.4 (C),169.6 (C),171.8 (C);
IR: n cmꢁ1 1738, 1717, 1654, 1432, 1262, 1209. Anal. Calcd for
4.6. Methyl 6,8-dibromo-7-[1-(methoxycarbonyl)propyl]-
5-oxo-1,2,3,5-tetrahydroindolizine-3-carboxylate (11)
C17H20ClNO7: C, 52.93; H, 5.23; N, 3.63. Found: C, 53.08; H, 5.34; N,
3.81.
The pyrrolopyridone 10 (600 mg, 2 mmol) was dissolved in
10 mL of dichloromethane. Solution of aq 48% HBr (6 mmol, 0.7 mL)
was added followed by iso-amyl nitrite (4 mmol, 0.9 mL). The re-
action mixture was stirred at room temperature for 6 h then
aqueous NaHCO3 (10 mL) was added and the mixture was extracted
by dichloromethane (2ꢃ20 mL). The combined organic layers were
dried then evaporated. The product was isolated by crystallization
and recrystallized in a mixture of ethyl acetate and ether. Yellow
powder; 84% yield; TLC Rf (AcOEt)¼0.7; mp (AcOEt) 69–70 ꢀC; 1H
NMR: (CDCl3, 200 MHz) d 0.97, 0.98 (2t, J¼7.3 Hz and J¼7.3 Hz, 3H,
CHCH2CH3), 1.87–2.15 (m, 2H, CHCH2CH3), 2.25–2.7 (m, 2H,
CH2CH2CH), 3.15–3.27 (m, 2H, CH2CH2CH), 3.7(s, 3H, CO2CH3), 3.82,
3.83 (2s, 3H, CO2CH3), 4.27–4.46 (br s, 1H, CHCH2CH3), 5.24, 5.25
(2dd, J¼9.5, 3.5 Hz and J¼9.5, 3.3 Hz, 1H, CH2CH2CH); 13C NMR:
(CDCl3, 50 MHz) d 11.9 (CH3), 22.5 (CH2), 25.4 (CH2), 33.7 (CH2), 52.5
(CH, CH3), 53.9 (CH3), 64.1 (CH), 148.9 (C), 150.4 (C), 156.5 (C), 168.0
(C),169.7 (C),171.4 (C); IR: n cmꢁ11738,1729,1642,1590,1549,1530,
1204. Anal. Calcd for C15H17Br2O5N$1⁄2 H2O: C, 39.16; H, 3.94; N,
3.04. Found: C, 39.31; H, 3.81; N; 3.16.
4.8. 5-Nitro-1,3-benzodioxole (14)
To a stirred solution of arene (5 mmol) and aq solution of HF 40%
(0.6 mL, 15 mmol) in a Teflon flask was added iso-amyl nitrite
(2 mmol, 0.4 mL). The mixture was stirred at room temperature for
3 days and the solvent was evaporated. The residue was diluted
with dichloromethane (10 mL) and washed with satd aqueous
NaHCO3 (5 mL). The aqueous phase was extracted with dichloro-
methane (2ꢃ10 mL) and the combined organic layers were dried
(MgSO4). The residue obtained upon evaporation was analyzed by
1H NMR and identified according to the literature data. 80% yield;
1H NMR: (CDCl3, 200 MHz) d 3.97, 3.99 (2s, 6H, OCH2O), 6.93 (d,
J¼8.9 Hz, 1H, ArH), 7.75 (d, J¼2.7 Hz, 1H, ArH), 7.92 (dd, J¼8.9,
2.7 Hz, 1H, ArH).
4.9. Brominated pyrroloquinazolinones
To a solution of compound 16 (1.0 g, 4.1 mmol) in dichloro-
methane (10 mL) were slowly added iso-amyl nitrite (1.6 mL,
8.0 mmol), then a solution of aq 48% HBr (1 mL, 3.6 mmol). The
reaction mixture was stirred at room temperature for 12 h. A sat-
urated aqueous solution of NaHCO3 was then added, and the mix-
ture was extracted with dichloromethane. The combined organic
layers were washed with water, then dried upon MgSO4 and
evaporated. The dark residue was then separated by HPLC using
a gradient of ethyl acetate in heptane to yield to cis and trans
monobrominated products 17 and dibrominated product 18.
4.6.1. Methyl 8-bromo-7-[1-(methoxycarbonyl)propyl]-5-oxo-
1,2,3,5-tetrahydroindolizine-3-carboxylate (12)
The pyrrolopyridone 10 (600 mg, 2 mmol) was dissolved in
10 mL of dichloromethane. Solution of aq 48% HBr (6 mmol, 0.7 mL)
was added followed by iso-amyl nitrite (4 mmol, 0.9 mL). The re-
action mixture was stirred at room temperature for 6 h then
aqueous NaHCO3 (10 mL) was added and the mixture was extracted
by dichloromethane (2ꢃ20 mL). The combined organic layers were
dried then evaporated. The residue was purified by chromatogra-
phy on SiO2 (heptane/EtOAc, 100/0% to 0/100%). Yellow oil; 78%
yield; TLC Rf (AcOEt)¼0.6; 1H NMR: (CDCl3, 200 MHz) d 0.96, 0.98
(2t, J¼7.4 and J¼7.3 Hz, 3H, CHCH2CH3), 1.66–2.14 (m, 2H,
CHCH2CH3), 2.24–2.67 (m, 2H, CH2CH2CH), 3.16–3.26 (m, 2H,
CH2CH2CH), 3.70, 3.71 (2s, 3H, CO2CH3), 3.75 (m, 1H, CHCH2CH3),
3.80, 3.81 (2s, 3H, CO2CH3), 5.19 (dd, J¼9.7, 3.4 Hz, 1H, CH2CH2CH),
6.43 (s, 1H, ArH); 13C NMR: (CDCl3, 50 MHz) d 11.0 (CH3), 25.3 (CH2),
25.6 (CH2), 33.0 (CH2), 51.0 (CH), 52.2 (CH3), 52.5 (CH3), 62.7 (CH),
97.5 (C), 116.9 (CH), 148.0 (C), 151.9 (C), 160 (C), 170 (C), 172 (C); IR:
n cmꢁ1 1738, 1670, 1596, 1533, 1438, 1339, 1210. Anal. Calcd for
4.9.1. Methyl 3-bromo-9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b]quin-
azoline-1-carboxylate (17)
4.9.1.1. Cis isomer. Grey powder; 10% yield; mp 124–126 ꢀC; TLC Rf
(EtOAc/Hept 50/50)¼0.26; 1H NMR: (CDCl3, 200 MHz) d 2.92 (dt,
J¼15.2, 1.5 Hz, 1H, CH–CH2–CHBr), 3.20 (ddd, J¼15.2, 9.4, 7.2 Hz, 1H,
CH–CH2–CHBr), 3.84 (s, 3H, CO2CH3), 5.22 (dd, J¼7.2,1.5 Hz,1H, CH–
CH2–CHBr), 5.29 (dd, J¼9.4, 1.5 Hz, 1H, CH–CH2–CHBr), 7.54 (dd,
J¼8.0, 6.1 Hz, 1H, Har), 7.79 (d, J¼8.2 Hz, 1H, Har), 7.81 (ddd, J¼8.2,
6.1, 1.5 Hz, 1H, Har), 8.33 (ddd, J¼8.0, 1.5, 0.7 Hz, 1H, Har); 13C NMR
(CDCl3, 50 MHz): d ppm 28.7 (CH2), 41.6 (CH3), 52.2 (CH), 56.7 (CH),
119.9 (C), 125.8 (CH), 126.6 (CH), 126.9 (CH), 133.8 (CH), 147.8 (C),
155.7 (C),158.9 (C), 167.8 (C); IR: n cmꢁ1 1751, 1667, 1631, 1214, 695;
1H NMR (CDCl3, 200 MHz). Anal. Calcd for C13H11BrN2O3$3⁄4 H2O: C,
46.38; H, 3.74; N, 8.32. Found: C, 46.06; H, 3.79; N, 8.67.
C
15H18BrNO5, H2O: C, 46.17; H, 5.17; N, 3.59. Found: C, 46.58; H,
4.85; N, 3.82.
4.7. Dimethyl 7-(1-(methoxycarbonyl)propyl)-1,2,3,5-tetra-
hydro-6-chloro-5-oxoindolizine-3,8-dicarboxylate (13)
A solution of 8 (300 mg, 0.85 mmol) in THF (4 mL), 37% hydro-
chloric acid (0.1 mL, 1.16 mmol) and iso-amyl nitrite (0.4 mL,
2.89 mmol) was stirred at room temperature for 1 week. The
mixture was neutralized by satd aqueous NaHCO3 (50 mL) and the
aqueous phase was extracted with dichloromethane (3ꢃ30 mL)
and the combined organic layers were dried (MgSO4) then evapo-
rated. The residue was purified by chromatography on SiO2 (hep-
tane/EtOAc,100/0% to 0/100%) to give compound 14. Yellow oil; 60%
yield; TLC Rf (AcOEt)¼0.6; 1H NMR: (CDCl3, 200 MHz) d 0.94, 0.95
(2t, J¼7.3 and J¼7.4 Hz, 3H, CHCH2CH3), 1.52–1.83 (m, 1H,
CHCH2CH3), 2.25–2.65 (m, 3H, CHCH2CH3 and CH2CH2CH3), 3.39–
3.51 (m, 2H, CH2CH2CH), 3.66 (m, 3H, CO2CH3), 3.79, 3.8 (2s, 3H,
4.9.2. Trans isomer
Grey powder; 22% yield; mp 132–134 ꢀC; TLC Rf (EtOAc/Hept 50/
50)¼0.41; 1H NMR (CDCl3, 200 MHz): d 2.91 (dd, J¼7.2, 5.8 Hz, 2H,
CH–CH2–CHBr), 3.85 (s, 3H, CO2CH3), 5.17 (t, J¼7.2 Hz, 1H, CH–CH2–
CHBr), 5.34 (t, J¼7.2 Hz, 1H, CH–CH2–CHBr), 7.52 (ddd, J¼7.9, 7.2,
1.9 Hz, 1H, Har), 7.78 (dd, J¼8.3, 1.9 Hz, 1H, Har), 7.80 (ddd, J¼8.3,
7.2, 1.1 Hz, 1H, Har), 8.29 (ddd, J¼7.9, 1.1 Hz, 1H, Har); 13C NMR
(CDCl3, 50 MHz): d ppm 28.7 (CH2), 41.6 (CH3), 52.2 (CH), 56.7 (CH),
119.9 (C), 125.8 (CH), 126.6 (CH), 126.9 (CH), 133.8 (CH), 147.8 (C),
155.7 (C),158.9 (C), 167.8 (C); IR: n cmꢁ1 1751, 1667, 1631, 1214, 695.
Anal. Calcd for C13H11BrN2O3$3⁄4 H2O: C, 46.38; H, 3.74; N, 8.32.
Found: C, 46.22; H, 3.72; N, 8.02.